Analgesic Efficacy and Safety of ADL5859 in Subjects With Acute Dental Pain After Third Molar Extraction
Clinical trial NCT00993863 · COMPLETED
Trial details
- NCT number
- NCT00993863
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2007-09-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.